Allergic Conjunctivitis Global Clinical Trials Review, H1, 2012

2012-02-29
Published : Feb-2012

Summary
GlobalData’s clinical trial report, “Allergic Conjunctivitis Global Clinical Trials Review, H1, 2012″ provides data on the Allergic Conjunctivitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Allergic Conjunctivitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Allergic Conjunctivitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease

Scope

– Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
– Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
– Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

– Understand the dynamics of a particular indication in a condensed manner
– Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
– Obtain discontinued trial listing for trials across the globe
– Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies


 Allergic Conjunctivitis Clinical Trials

Published: February 2012
No. of Pages: 91
Price: US$1000

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Allergic Conjunctivitis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Allergic Conjunctivitis 23
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Allergic Conjunctivitis Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Novartis AG 31
Clinical Trial Overview of Novartis AG 31
VISTAKON Pharmaceuticals, LLC 32
Clinical Trial Overview of VISTAKON Pharmaceuticals, LLC 32
Bausch & Lomb Incorporated 33
Clinical Trial Overview of Bausch & Lomb Incorporated 33
ISTA Pharmaceuticals, Inc. 34
Clinical Trial Overview of ISTA Pharmaceuticals, Inc. 34
Merck & Co., Inc. 35
Clinical Trial Overview of Merck & Co., Inc. 35
ORA, Inc. 36
Clinical Trial Overview of ORA, Inc. 36
Allergopharma Joachim Ganzer KG 37
Clinical Trial Overview of Allergopharma Joachim Ganzer KG 37
Alcon, Inc. 38
Clinical Trial Overview of Alcon, Inc. 38
Allergan, Inc. 39
Clinical Trial Overview of Allergan, Inc. 39
LABORATOIRES THEA 40
Clinical Trial Overview of LABORATOIRES THEA 40
Laboratorios LETI S.L. 41
Clinical Trial Overview of Laboratorios LETI S.L. 41
Aciex Therapeutics, Inc. 42
Clinical Trial Overview of Aciex Therapeutics, Inc. 42
Santen Pharmaceutical Co., Ltd. 43
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 43
ALK-Abello A/S 44
Clinical Trial Overview of ALK-Abello A/S 44
Cytos Biotechnology AG 45
Clinical Trial Overview of Cytos Biotechnology AG 45
Ajanta Pharma Limited 46
Clinical Trial Overview of Ajanta Pharma Limited 46
Inspire Pharmaceuticals, Inc. 47
Clinical Trial Overview of Inspire Pharmaceuticals, Inc. 47
Alcon Research Ltd. 48
Clinical Trial Overview of Alcon Research Ltd. 48
HAL Allergy BV 49
Clinical Trial Overview of HAL Allergy BV 49
Fovea Pharmaceuticals SA 50
Clinical Trial Overview of Fovea Pharmaceuticals SA 50
Clinical Trial Overview of Top Universities / Institutes / Hospitals 51
Helsinki University Central Hospital 51
Clinical Trial Overview of Helsinki University Central Hospital 51
Gujarat Ayurved University 52
Clinical Trial Overview of Gujarat Ayurved University 52
Japanese Ocular Allergology Society 53
Clinical Trial Overview of Japanese Ocular Allergology Society 53
Hom, Milton M., OD, FAAO 54
Clinical Trial Overview of Hom, Milton M., OD, FAAO 54
Eye Therapies, LLC 55
Clinical Trial Overview of Eye Therapies, LLC 55
Ophthalmic Research Associates, Inc 56
Clinical Trial Overview of Ophthalmic Research Associates, Inc 56
Department of Health 57
Clinical Trial Overview of Department of Health 57
University of Udine 58
Clinical Trial Overview of University of Udine 58
Aarhus University Hospital 59
Clinical Trial Overview of Aarhus University Hospital 59
Southern California College of Optometry 60
Clinical Trial Overview of Southern California College of Optometry 60
Campus Bio-Medico University Rome 61
Clinical Trial Overview of Campus Bio-Medico University Rome 61
Rush University Medical Center 62
Clinical Trial Overview of Rush University Medical Center 62
Assaf-Harofeh Medical Center 63
Clinical Trial Overview of Assaf-Harofeh Medical Center 63
Vanderbilt University 64
Clinical Trial Overview of Vanderbilt University 64
Philipps University Marburg Medical Center 65
Clinical Trial Overview of Philipps University Marburg Medical Center 65
University of Wisconsin Madison 66
Clinical Trial Overview of University of Wisconsin Madison 66
Charite University 67
Clinical Trial Overview of Charite University 67
Five Key Clinical Profiles 68
Appendix 88
Abbreviations 88
Definitions 88
Research Methodology 89
Secondary Research 89
About GlobalData 90
Contact Us 90
Disclaimer 90
Source 91

List of Tables
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Allergic Conjunctivitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Allergic Conjunctivitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Allergic Conjunctivitis Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Allergic Conjunctivitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Allergic Conjunctivitis Therapeutics Clinical Trials, BRIC Countries, 2012* 15
Allergic Conjunctivitis Therapeutics Clinical Trials, G7 Countries, 2012* 16
Allergic Conjunctivitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
Allergic Conjunctivitis Therapeutics Clinical Trials, E7 Countries, 2012* 18
Allergic Conjunctivitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials by Phase, 2012* 20
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 21
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
Allergic Conjunctivitis Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 23
Allergic Conjunctivitis Therapeutics Market, Global, Terminated Clinical Trials, 2012* 24
Allergic Conjunctivitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25
Allergic Conjunctivitis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27
Allergic Conjunctivitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 29
Allergic Conjunctivitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 30
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 31
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by VISTAKON Pharmaceuticals, LLC, 2012* 32
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bausch & Lomb Incorporated, 2012* 33
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by ISTA Pharmaceuticals, Inc., 2012* 34
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 35
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by ORA, Inc., 2012* 36
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergopharma Joachim Ganzer KG, 2012* 37
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon, Inc., 2012* 38
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2012* 39
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by LABORATOIRES THEA, 2012* 40
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios LETI S.L., 2012* 41
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aciex Therapeutics, Inc., 2012* 42
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2012* 43
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by ALK-Abello A/S, 2012* 44
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytos Biotechnology AG, 2012* 45
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ajanta Pharma Limited, 2012* 46
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Inspire Pharmaceuticals, Inc., 2012* 47
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon Research Ltd., 2012* 48
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by HAL Allergy BV, 2012* 49
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fovea Pharmaceuticals SA, 2012* 50
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2012* 51
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gujarat Ayurved University, 2012* 52
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Ocular Allergology Society, 2012* 53
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hom, Milton M., OD, FAAO, 2012* 54
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eye Therapies, LLC, 2012* 55
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthalmic Research Associates, Inc, 2012* 56
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, 2012* 57
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Udine, 2012* 58
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University Hospital, 2012* 59
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Southern California College of Optometry, 2012* 60
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Campus Bio-Medico University Rome, 2012* 61
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2012* 62
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2012* 63
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 64
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Philipps University Marburg Medical Center, 2012* 65
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 66
Allergic Conjunctivitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2012* 67

 

List of Figures

Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Allergic Conjunctivitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Allergic Conjunctivitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Allergic Conjunctivitis Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Allergic Conjunctivitis Therapeutics Clinical Trials, BRIC Countries (%), 2012* 15
Allergic Conjunctivitis Therapeutics Clinical Trials, G7 Countries (%), 2012* 16
Allergic Conjunctivitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
Allergic Conjunctivitis Therapeutics Clinical Trials, E7 Countries (%), 2012* 18
Allergic Conjunctivitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21
Allergic Conjunctivitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
Allergic Conjunctivitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 25
Allergic Conjunctivitis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26
Allergic Conjunctivitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 28
Allergic Conjunctivitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 30
GlobalData Methodology 89

 

Filed in: Pharmaceutical
Tags: 
More Reports
Title Price Buy Now

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

“The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......
 $4950

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

“The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......
 $

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

“Digital Pharmacy market to register a CAGR of 17.0%  during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated  to grow at the highest rate during the forecast period” On the basis  ofdrug type, t......
 $4950

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......
 $4950

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases,  growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders,  rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on  product in 2021.” Based on products, the topical drug delivery the market is segmented into ......
 $4950

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

“Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......
 $4950

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......
 $4950

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

“Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......
 $4950

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

“Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......
 $4950

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027

The global Healthcare cloud computing market is projected to reach USD 89.4  billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......
 $4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy